Navigation Links
ATS Labs, Inc. Announces the Acquisition of MicroTest Labs, Inc.

EAGAN, Minn., July 14, 2014 /PRNewswire/ -- Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA.  The acquisition of MTL is the first step in the strategy of ATS to expand its microbiology and chemistry laboratory services platform to support the medical device and biopharmaceutical industries.  The combined companies will soon be known as Accuratus Lab Services, a name that personifies the quality and accuracy of testing results and scientific solutions that support the antimicrobial, consumer product, medical device, and biopharmaceutical industries.

"The acquisition of MicroTest by ATS has been a long time in the making and I could not be more pleased about the future of the two companies and how they will combine to create the market leader in providing microbiology and analytical chemistry testing services," said Dr. Steve Richter, CEO of MTL.  Dr. Tom Burnell, Executive Chairman of ATS added, "Like ATS, MicroTest has a strong reputation in the industries it serves, which is supported by long-standing client relationships. Leveraging the strengths of the two companies will only further enhance our ability to continuously exceed our client's expectations."  It is expected that administrative functions will be consolidated, but the company will continue to operate at its locations in Eagan, MN and Agawam, MA.

About ATS Labs:ATS Labs is the leading global provider of antimicrobial and biocide testing services; committed to improving public health and generating value for customers.  ATS Labs has been an expert partner to the developers, manufacturers, and users of antimicrobial products for over 20 years; providing a comprehensive range of microbiology, virology, and product chemistry services.  For more information on ATS Labs go to

About MicroTest Labs:MicroTest Labs is a leader in testing services for the medical device, pharmaceutical and biotechnology industries.  Founded in 1984, the company's expertise and flexible processes enhance product safety and security, speed time to market, and minimize supply chain disruption.  For more information on MicroTest Labs go to

About Ampersand Capital Partners:Ampersand is a middle market private equity firm with a focus on growth equity investments in the Healthcare sector.  Over the past two decades, Ampersand has managed $1 billion in private equity partnerships.  Ampersand leverages its unique blend of private equity and operating experience to build value and drive superior long-term performance alongside its portfolio company management teams.  Additional information about Ampersand is available at More Information:Dr. Tom Burnell

ATS Labs, Inc.Executive Chairman 

1285 Corporate Center DriveEmail: 

Suite 110(402) 613-4184 

Eagan, MN 55121Logo -

Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Endexx Enters Into Definitive Agreement to Acquire Dispense Labs, LLC
2. PharmaRoth Labs, Inc. Announces Trading Symbol Change
3. PharmaRoth Labs, Inc. Files New Dietary Ingredient Notification with the US Food and Drug Administration (FDA)
4. Fero Industries, Inc. Changes Name to PharmaRoth Labs, Inc.
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics
7. Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc.
8. ISSI Announces Fiscal 2014 Third Quarter Conference Call
9. CVS Caremark Corporation Announces Quarterly Dividend
10. Sono-Tek Announces Third Quarter Results
11. Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Thanks to ... Dignity Health St. Mary,s Medical Center,s Sister Diane Grassilli ... breast imaging capabilities in San Francisco ... an anonymous friend, stepped forward with a gift of ... for Breast Digital Mammography with Tomosynthesis and Whole Breast ...
(Date:11/24/2015)... Colo. , Nov. 24, 2015  Array ... that its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public is ... webcast on the Array BioPharma website.Event:Piper Jaffray Annual ... , Wednesday, December 2, 2015Time:1:30 p.m. Eastern Time ...
(Date:11/24/2015)... HOUSTON, TX and VANCOUVER, Nov. 24, 2015 /PRNewswire/ ... EPI; NASDAQ: EPIX ) announced today that the ... clinical study of EPI-506 as a treatment for metastatic ... States and Canada.  --> ... --> In the Phase 1/2 clinical trial, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I ... Bronx, N.Y. “I thought there had to be a convenient and comfortable way to ... The PROTECTOR enables disabled individuals to safely travel during cold or inclement weather. In ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in 2012, ... adult stem cell therapies to patients with chronic degenerative medical conditions. Now, the ... Registered Trademark (RTM). , Organizations are required to hold a registered trademark in ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software ... software creates an agreement between the practice owner and the patient that automatically ... notification, and projections. Click here to learn more. , ...
Breaking Medicine News(10 mins):